NCT04834635Completed
The FundoRingOAGB Versus Non-wrapping (Non-banded) Standard Method of Laparoscopic One Anastomosis Gastric Bypass
The Total Wrapping of the Fundus of the Gastric Excluded Part (FundoRing) Versus Non- Wrapping (Non-banded) Standard Method of Laparoscopic One Anastomosis Gastric Bypass/Mini - Gastric Bypass: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 19 May 2026
Brief summary (registry, in English)
Currently, one anastomosis gastric bypass (OAGB) or mini-gastric bypass (MGB) is a common bariatric procedure for treating obesity. Weight gain after surgery is a big problem in bariatric practice. Therefore, adjustable bands and rings are used, for example, "FobiRing". But foreign material can cause complications - the erosion of the stomach wall. For this reason, surgeons avoid the use of various mechanical devices on living tissues. The greatest criticism is of the OAGB for the likelihood of biliary reflux. In case of reflux of bile into the esophagus after surgery, as a rule, a second operation is required with conversion OAGB to the Roux-en-Y method. In addition, along with obesity, gastroesophageal reflux disease (GERD) are steadily increasing world weight and antireflux surgery must be performed simultaneously with bariatric surgery in obese patients. In these cases, most often in bariatric practice, hiatus cruroraphy is performed, and less often fundoplication using the fundus of the excluded part of the stomach. We hypothesize that total fundoplication can not only treat GERD but also significant prevent the return of weight like after a banded gastric bypass and prevent postoperative bile reflux in the esophagus. The aim study is to compare primary outcome as weight loss after total wrapping of the fundus of the gastric excluded part (FundoRing) and non - wrapping (non - banded) standard method of laparoscopic one anastomosis gastric bypass and measure secondary outcome: bile reflux in the esophagus and GERD symptoms. Methods: Adult participants (n=1000) are randomly allocated to one of two groups: Experimental surgical bariatric procedure in the first (A) group: patients (n=500) undergo the laparoscopic one anastomosis gastric bypass with the total wrapping of the fundus of gastric excluded part and suture cruroplasty if present hiatal hernia (FundoRingOAGB group); Active comparator surgical bariatric procedure in the second (B) group: patients (n=500) undergo the laparoscopic one anastomosis gastric bypass and with only suture cruroplasty if present hiatal hernia (OAGB group).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 1000 (actual)
- First submitted
- 4 Apr 2021
- Start date
- 29 Mar 2021
- Primary completion date
- 5 Apr 2024
- Lead sponsor
- The Society of Bariatric and Metabolic Surgeons of Kazakhstan
- Diseases
- Obesity
- NCT number
- NCT04834635
What you commit to
- Study type: Interventional
- Participants enrolled: 1000
- From 29 Mar 2021 to the primary completion date, 5 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Not fit for bariatric surgery
Other illness
- History of surgery on the stomach or esophagus
- Psychiatric illness
Age
- Less than 18 or more than 60 years of age
Other
- BMI less than 30 kg / m2 and more than 50 kg / m2.
- Prosthetic (mesh) Hiatal herniorrhaphy or large hiatal hernia;
- Esophageal shortening
- Los Angeles Classification of Oesophagitis (LA grade) C or D reflux esophagitis
- Patients unwilling or unable to provide informed consent
Who the study is looking for
- BMI from 30 to 50 kg / m2.
- The person is generally fit for anesthesia (ASA grading 1-2) and surgery.
- The person commits to the need for long-term follow-up.
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Oral Ospanov Coordinator of this site? Confirm its status | Astana | Kazakhstan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.